Literature DB >> 33476541

[Clinical features of children with Mycoplasma pneumoniae pneumonia and peripheral lymphocytopenia].

Li Peng1, Li-Li Zhong1, Zhen Huang1, Yan Li1, Bing Zhang1.   

Abstract

OBJECTIVE: To study the clinical features of children with Mycoplasma pneumoniae pneumonia (MPP) and peripheral lymphocytopenia.
METHODS: A total of 310 MPP children who were hospitalized and underwent bronchoalveolar lavage from June 2018 to June 2019 were enrolled and divided into two groups: simple MPP group with 241 children (without peripheral lymphocytopenia) and MPP + peripheral lymphocytopenia group with 69 children. The two groups were compared in terms of clinical data and treatment outcome.
RESULTS: Compared with the simple MPP group, the MPP + peripheral lymphocytopenia group had significantly longer duration of fever and length of hospital stay and significant increases in C-reactive protein, lactate dehydrogenase, and Mycoplasma pneumoniae DNA copies in bronchoalveolar lavage fluid (P < 0.05). Compared with the simple MPP group, the MPP + peripheral lymphocytopenia group had significantly higher incidence rates of intrapulmonary consolidation, extrapulmonary complications, and serious lesions under bronchoscopy (erosion or sputum bolt) and a significantly higher proportion of patients with severe MPP (P < 0.05).
CONCLUSIONS: Children with MPP and peripheral lymphocytopenia tend to have more severe immunologic injury. Peripheral blood lymphocyte count may be used to evaluate the severity of MPP.

Entities:  

Year:  2021        PMID: 33476541      PMCID: PMC7818155     

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  11 in total

1.  Interferon gamma and interleukin 4 have contrasting effects on immunopathology and the development of protective adaptive immunity against mycoplasma respiratory disease.

Authors:  Sheetal Bodhankar; Xiangle Sun; Matthew D Woolard; Jerry W Simecka
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

2.  Increased T cell activation in BALF from children with Mycoplasma pneumoniae pneumonia.

Authors:  Li Guo; Fang Liu; Mei-Ping Lu; Qi Zheng; Zhi-Min Chen
Journal:  Pediatr Pulmonol       Date:  2014-08-26

Review 3.  Community-Acquired Pneumonia in Children.

Authors:  Alexander K C Leung; Alex H C Wong; Kam L Hon
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2018

4.  Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings.

Authors:  Christian Obirikorang; Lawrence Quaye; Isaac Acheampong
Journal:  BMC Infect Dis       Date:  2012-06-07       Impact factor: 3.090

Review 5.  Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications.

Authors:  Takeshi Saraya; Daisuke Kurai; Kazuhide Nakagaki; Yoshiko Sasaki; Shoichi Niwa; Hiroyuki Tsukagoshi; Hiroki Nunokawa; Kosuke Ohkuma; Naoki Tsujimoto; Susumu Hirao; Hiroo Wada; Haruyuki Ishii; Koh Nakata; Hirokazu Kimura; Kunihisa Kozawa; Hajime Takizawa; Hajime Goto
Journal:  Front Microbiol       Date:  2014-08-11       Impact factor: 5.640

6.  Cytokines as the good predictors of refractory Mycoplasma pneumoniae pneumonia in school-aged children.

Authors:  Yuanyuan Zhang; Shufen Mei; Yunlian Zhou; Meixia Huang; Guijuan Dong; Zhimin Chen
Journal:  Sci Rep       Date:  2016-11-11       Impact factor: 4.379

Review 7.  Mycoplasma pneumoniae infection: Basics.

Authors:  Takeshi Saraya
Journal:  J Gen Fam Med       Date:  2017-04-17

8.  Mycoplasma Pneumoniae Pneumonia: Walking Pneumonia Can Cripple the Susceptible.

Authors:  Bharat Bajantri; Omesh Toolsie; Sindhaghatta Venkatram; Gilda Diaz-Fuentes
Journal:  J Clin Med Res       Date:  2018-10-30

9.  Increased procalcitonin level is a risk factor for prolonged fever in children with Mycoplasma pneumonia.

Authors:  Ji Eun Jeong; Ji Eun Soh; Ji Hee Kwak; Hye Lim Jung; Jae Won Shim; Deok Soo Kim; Moon Soo Park; Jung Yeon Shim
Journal:  Korean J Pediatr       Date:  2018-08-15

Review 10.  Mycoplasma pneumoniae: A Potentially Severe Infection.

Authors:  Bharat Bajantri; Sindhaghatta Venkatram; Gilda Diaz-Fuentes
Journal:  J Clin Med Res       Date:  2018-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.